Leaderboards/Ethics in Clinical Research

Ethics in Clinical Research

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Changyu Wang
West China Medical Center of Sichuan University
2
Dana Brin
Tel Aviv University
3
Ruishan Liu
National Centre for Infectious Diseases
4
Mohammed Adnan
National University of Sciences and Technology
5
Thomas Yu Chow Tam
University of Pittsburgh
6
Melissa D. McCradden
3M (United States)
7
Randall A. Oyer
Lancaster General Hospital
8
Ken Masters
Apple (Israel)
9
Mike Fillon
National Cancer Institute
10
Hanhui Xu
Fudan University

Rising Stars Papers

1
A framework for human evaluation of large language models in healthcare derived from literature review
npj Digital Medicine|2024
284 cit.
2
Assessing GPT-4 multimodal performance in radiological image analysis
European Radiology|2024
76 cit.
3
Artificial Intelligence in Health Professions Education assessment: AMEE Guide No. 178
Medical Teacher|2025
46 cit.
4
Twelve tips on creating and using custom GPTs to enhance health professions education
Medical Teacher|2024
44 cit.
5
Preparing for Artificial General Intelligence (AGI) in Health Professions Education: AMEE Guide No. 172
Medical Teacher|2024
40 cit.
6
Family roles in informed consent from the perspective of young Chinese doctors: a questionnaire study
BMC Medical Ethics|2024
28 cit.
7
A checklist for reporting, reading and evaluating Artificial Intelligence Technology Enhanced Learning (AITEL) research in medical education
Medical Teacher|2024
22 cit.
8
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 165,912 US patients
Cell Reports Medicine|2024
20 cit.
9
Pedagogy and generative artificial intelligence: Applying the PICRAT model to Google NotebookLM
Medical Teacher|2024
14 cit.
10
Explaining decisions without explainability? Artificial intelligence and medicolegal accountability
Future Healthcare Journal|2024
13 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Marc T. Avey
ICF International (United States)
2
Viki Hurst
National Centre for the Replacement Refinement and Reduction of Animals in Research
3
Frances Rawle
Medical Research Council
4
Sabina Alam
Taylor and Francis (United Kingdom)
5
Gemma Buckland‐Merrett
Pfizer (United States)
6
Karin Jongsma
University Medical Center Utrecht
7
Kanwal Raghav
The University of Texas MD Anderson Cancer Center
8
Rieke van der Graaf
University Medical Center Utrecht
9
Katie Gillies
University of Aberdeen
10
Haksoo Ko
Seoul National University

Emerging Leaders Papers

1
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
The Lancet Oncology|2024
126 cit.
2
Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplified (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study.
Journal of Clinical Oncology|2023
77 cit.
3
What, how, when and who of trial results summaries for trial participants: stakeholder-informed guidance from the RECAP project
BMJ Open|2022
67 cit.
4
Integrating artificial intelligence in pathology: a qualitative interview study of users' experiences and expectations
Modern Pathology|2022
49 cit.
5
Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)
Journal of Clinical Oncology|2022
38 cit.
6
Behavioural approaches to recruitment and retention in clinical trials: a systematic mapping review
BMJ Open|2022
37 cit.
7
Core outcome set for symptomatic uncomplicated gallstone disease
British journal of surgery|2022
27 cit.
8
Why we should not mistake accuracy of medical AI for efficiency
npj Digital Medicine|2024
27 cit.
9
Feasibility and value of genomic profiling in cancer of unknown primary: real-world evidence from prospective profiling study
JNCI Journal of the National Cancer Institute|2023
21 cit.
10
What influences communication about retention in randomised trials: a multi-trial, theory-based analysis exploring trial staff perspectives
BMC Medical Research Methodology|2022
18 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Hanno Würbel
University of Bern
2
David Moher
University of Ottawa
3
Effy Vayena
ETH Zurich
4
Amrita Ahluwalia
Queen Mary University of London
5
Ulrich Dirnagl
German Center for Neurodegenerative Diseases
6
Christine Grady
National Institutes of Health Clinical Center
7
Luciano Floridi
Data Power Decisions (United States)
8
Paula Williamson
University of Liverpool
9
Malcolm Macleod
University of Edinburgh
10
Thomas Steckler
Janssen (Belgium)

Current Senior Leaders Papers

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
BMJ|2021
95k cit.
2
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ|2009
83.3k cit.
3
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
PLoS Medicine|2009
64.1k cit.
4
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
PubMed|2009
45.1k cit.
5
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Annals of Internal Medicine|2009
37.9k cit.
6
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Journal of Clinical Epidemiology|2009
19.9k cit.
7
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
BMC Medicine|2010
13.5k cit.
8
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Systematic Reviews|2021
13.5k cit.
9
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
International Journal of Surgery|2010
12k cit.
10
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
International Journal of Surgery|2021
11.5k cit.

Reagents for Ethics in Clinical Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

Phospho-PAK1 (Ser144)/PAK2 (Ser141) Antibody

#2606$152,362
View Evidence →
Cell Signaling TechnologyEvidence 67

beta-Actin (13E5) Rabbit Monoclonal Antibody (HRP Conjugate)

#5125$477
View Evidence →
Cell Signaling TechnologyEvidence 67

DUSP6/MKP3 Antibody

#50945$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 62

Nonactin

Cited in 5 papers
#76040$134
View Evidence →
Cell Signaling TechnologyEvidence 63

Cas9 (S. pyogenes) Matched Antibody Pair

#19707$1,726
View Evidence →
Cell Signaling TechnologyEvidence 65

GATA-6 (D61E4) Rabbit Monoclonal Antibody (SignalFlex™ Pacific Blue™ Conjugate)

#71954$458
View Evidence →